These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1596047)

  • 1. Valve disease associated with ergot alkaloid use: echocardiographic and pathologic correlations.
    Redfield MM; Nicholson WJ; Edwards WD; Tajik AJ
    Ann Intern Med; 1992 Jul; 117(1):50-2. PubMed ID: 1596047
    [No Abstract]   [Full Text] [Related]  

  • 2. From headache to heartache: ergotamine-induced aortic and mitral valvulopathy.
    Patel SM; Ohori NP; Badhwar V; Cavalcante JL
    J Am Coll Cardiol; 2013 Dec; 62(22):2144. PubMed ID: 24067402
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ergotamine-induced heart valve fibrosis and coronary microangiopathy?].
    Creutzig A
    Dtsch Med Wochenschr; 1992 Nov; 117(45):1736. PubMed ID: 1425287
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of heart valve lesions during methysergide therapy.
    Misch KA
    Br Med J; 1974 May; 2(5915):365-6. PubMed ID: 4835843
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac surgery for ergotamine-induced multivalvular heart disease.
    Lazopoulos G; Papaioannou G; Kantartzis M
    Thorac Cardiovasc Surg; 2013 Aug; 61(5):435-7. PubMed ID: 23475795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart valve disease associated with treatment with ergot-derived dopamine agonists: a clinical and echocardiographic study of patients with Parkinson's disease.
    Rasmussen VG; Poulsen SH; Dupont E; Østergaard K; Safikhany G; Egeblad H
    J Intern Med; 2008 Jan; 263(1):90-8. PubMed ID: 18036161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Limb ischemia and mitral valve defect as complication of migraine medication].
    Pohjola-Sintonen S
    Duodecim; 1992; 108(6):558-61. PubMed ID: 1366115
    [No Abstract]   [Full Text] [Related]  

  • 8. Ergotamine-associated valvulopathy with recurrent chylous pleural effusion.
    Bois JP; Ponnada VV; O'Cochlain DF; Brady PA; Edwards WD; Klarich KW
    Tex Heart Inst J; 2012; 39(5):736-8. PubMed ID: 23109782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical case of the month. Triple valvular dysfunction associated with long-term ergotamine therapy].
    Goujon-Dubois J; el Allaf D
    Rev Med Liege; 2003 Feb; 58(2):70-2. PubMed ID: 12693305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart abnormalities in Parkinson patients after discontinuation or continuation of ergot-derived dopamine agonists: a treatment-blinded echocardiographic study.
    Rasmussen VG; Poulsen SH; Dupont E; Østergaard K; Safikhany G; Egeblad H
    J Heart Valve Dis; 2009 Jul; 18(4):463-9. PubMed ID: 19852154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists.
    Horvath J; Fross RD; Kleiner-Fisman G; Lerch R; Stalder H; Liaudat S; Raskoff WJ; Flachsbart KD; Rakowski H; Pache JC; Burkhard PR; Lang AE
    Mov Disord; 2004 Jun; 19(6):656-62. PubMed ID: 15197703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs for migraine.
    Med Lett Drugs Ther; 1976 Jun; 18(13):55-6. PubMed ID: 934019
    [No Abstract]   [Full Text] [Related]  

  • 13. Aortic and mitral valve disease induced by ergotamine therapy for migraine: a case report and review of the literature.
    Hendrikx M; Van Dorpe J; Flameng W; Daenen W
    J Heart Valve Dis; 1996 Mar; 5(2):235-7. PubMed ID: 8665020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists.
    Kim JY; Chung EJ; Park SW; Lee WY
    Mov Disord; 2006 Aug; 21(8):1261-4. PubMed ID: 16685692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitral valve disease associated with long-term ergotamine use.
    Austin SM; el-Hayek A; Comianos M; Tamulonis DJ
    South Med J; 1993 Oct; 86(10):1179-81. PubMed ID: 8211344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitral and aortic valve disease associated with ergotamine therapy for migraine. Report of two cases and review of literature.
    Hauck AJ; Edwards WD; Danielson GK; Mullany CJ; Bresnahan DR
    Arch Pathol Lab Med; 1990 Jan; 114(1):62-4. PubMed ID: 2403780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitral heart disease due to cabergoline.
    Martin M; Iglesias-Cubero G; Diaz Molina B; Moris De la Tassa C
    Int J Cardiol; 2007 Jan; 114(1):e7-8. PubMed ID: 17052783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The link between drug use and heart valve disease].
    Grinberg M; Halpern A; Rossi EG; Leite CC; Sbano JC
    Arq Bras Cardiol; 1998 Mar; 70(3):181-3. PubMed ID: 9674180
    [No Abstract]   [Full Text] [Related]  

  • 19. Mitral regurgitation occurring during methsergide (Sansert) therapy.
    Munroe DS; Allen P; Cox AR
    Can Med Assoc J; 1969 Nov; 101(9):62-5. PubMed ID: 5348490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Postoperative echocardiographic follow-up in patients with mitral and aortic valve disease (author's transl)].
    Haerten K; Köhler E; Völz G; Herzer JA
    Z Kardiol; 1979 May; 68(5):357-66. PubMed ID: 463193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.